MetLife, Inc. (MET)

NYSE: MET · USD

$99.6

-0.38 (-0.4%)· Recorded snapshot

Market cap	63.3B
Revenue (ttm)	79.4B
Net income (ttm)	3.4B
EPS (ttm)	$5.22
Shares out	635.5M
P/E (trailing)	19.1x
P/E (forward)	9.2x
Dividend	$2.37 (2.38%)
Volume	1,427,496
Beta	0.77

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 79.4B
Net income (ttm): 3.4B
EPS (ttm): $5.22
P/E (trailing): 19.1x
P/E (forward): 9.2x
Market cap: 63.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ACGL	Arch Capital Group Ltd.	34.8B	8.3x	1.8x	15.9%	+15.1%	+18.7%	Активно покупать
AIG	American International Group Inc.	41.7B	14.7x	1.6x	7.7%	-9.6%	+2.8%	Активно покупать
AIZ	Assurant, Inc.	14.1B	13.6x	1.0x	14.4%	+6.6%	+36.2%	Держать

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E9.2

P25 n/aP50 n/aP75 n/a

Trailing P/E19.1

P25 n/aP50 n/aP75 n/a

ROE13.1

P25 n/aP50 n/aP75 n/a

ROIC5.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MET indicators

Market & fundamental data

Available fields

251

Groups with data

Currency

USD

Showing 251 of 251 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001099219
Company name	MetLife, Inc.
Country	United States
Country code	US
CUSIP number	59156R108
Earnings date	2026-11-04
Earnings time	amc
Employees	46,000
Employees change	1,000
Employees growth	2.22%
Enterprise value	$94.3B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1863
In index	SP500
Industry	Insurance - Life
Is primary listing	Yes
Is SPAC	No
ISIN number	US59156R1086
Last 10-K release date	2026-02-19
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$63.3B
Market cap category	Large-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$99.60
Price currency	USD
Sector	Financials
SIC code	6311
Stock price date	2026-10-28
Symbol	MET
U.S. state	New York
Website	https://www.metlife.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	10.26x
Average P/E ratio (10Y)	21.7x
Average P/E ratio (3Y)	17.92x
Average P/E ratio (5Y)	14.94x
Earnings yield	5.24%
EV/Earnings	27.48x
EV/EBIT	17.93x
EV/EBITDA	15.66x
EV/Sales	1.19x
Forward EV/Sales	1.16x
Forward P/E	9.21x
Forward P/S	0.78x
Graham number	71.06172
Graham upside	-28.95%
Industry forward P/E	9.9x
Industry P/E	12.37x
Lynch fair value	$26.08
Lynch upside	-73.92%
P/B ratio	2.32x
P/E ratio	19.09x
P/OCF ratio	4.08x
P/S ratio	0.8x
PEG ratio	0.69x
Price / tangible book value	3.55x
Price/EBITDA ratio	10.52x
Sector forward P/E	13.61x
Sector P/E	15.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.64%
EBITDA margin	7.61%
Effective tax rate	24.85%
Gross margin	23.95%
Operating margin	6.64%
Pretax margin	6.13%
Profit margin	4.57%
Profit per employee	$74,804
Profitable quarters	35
Profitable years	16
Revenue per employee	$1.7M
ROA	0.45%
ROA (5Y)	0.43%
ROCE	0.74%
ROE	13.09%
ROE (5Y)	10.63%
ROIC	5.1%
ROIC (5Y)	3.27%
Tax / revenue	1.52%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-11.97%
EPS growth (Q)	5.83%
EPS growth (QoQ)	-37.36%
EPS growth 10Y	3.19%
EPS growth 3Y	10.54%
EPS growth 5Y	1.21%
EPS growth quarters	2
EPS growth years	0
Net income growth	-15.42%
Net income growth (Q)	0.96%
Net income growth (QoQ)	-38.16%
Net income growth 3Y	4.32%
Net income growth 5Y	-4.85%
Net income growth quarters	2
Net income growth years	0
OCF growth	2.16%
OCF growth (Q)	1.88%
OCF growth (QoQ)	-17.08%
OCF growth 10Y	1.47%
OCF growth 3Y	10.04%
OCF growth 5Y	4.15%
Revenue growth	8.74%
Revenue growth (Q)	10.46%
Revenue growth (QoQ)	0.42%
Revenue growth 10Y	1.67%
Revenue growth 3Y	4.34%
Revenue growth 5Y	2.69%
Revenue growth quarters	3
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	$5.3B
EBITDA	$6B
EPS	$5.22
Financing cash flow	$5.3B
Gross profit	$19B
Income taxes	$1.2B
Investing cash flow	$-23.6B
Net borrowing	$1B
Net cash flow	$-2.9B
Net income	$3.4B
Operating income	$5.3B
Revenue	$79.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$43.03
Debt / EBITDA	8.06
Debt / equity	1.8
Goodwill	$9.5B
Interest coverage	4.84
Net cash (debt)	$-31B
Net cash / market cap	-48.79%
Net debt / EBITDA	5.13
Net debt / equity	1.11
Piotroski F-Score	6
Shareholders' equity	$28B
Tangible book value	$17.9B
Tangible book value per share	$28.08
Total assets	$759.4B
Total cash	$27.3B
Total debt	$50.3B
Total liabilities	$731.4B
WACC	5.47%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.11
Current ratio	2.03
Net working capital	$52.1B
Quick ratio	1.7
Working capital	$48B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	4.7%
Dividend growth	4.34%
Dividend growth (10Y)	4.06%
Dividend growth (3Y)	4.41%
Dividend growth (5Y)	4.3%
Dividend growth years	13
Dividend payment date	2026-12-08
Dividend payment years	27
Dividend payout frequency	Quarterly
Dividend per share	$2.37
Dividend yield	2.38%
Ex-dividend date	2026-11-03
Last dividend	$0.59
Payout ratio	45.44%
Shareholder yield	7.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	108.33%
10Y return CAGR	12.53%
10Y total return	225.45%
150-day SMA	$89.07
15Y price change	178.53%
15Y return CAGR	11.39%
15Y total return	404.32%
1D price change	-0.38%
1M price change	1.69%
1M total return	1.69%
1W price change	-1.81%
1W total return	-1.81%
1Y price change	25.97%
1Y return CAGR	29.58%
1Y total return	29.56%
20-day SMA	$99.08
200-day SMA	$85.46
20Y price change	69.37%
20Y return CAGR	6.2%
20Y total return	232.99%
3M price change	4.37%
3M total return	5.02%
3Y price change	70.44%
3Y return CAGR	23.04%
3Y total return	86.28%
50-day SMA	$97.43
50-day SMA vs 200-day SMA	50over200
52-week high	$103.65
52-week high date	2026-10-22
52-week low	$67.33
52-week low date	2026-03-27
5Y price change	54.53%
5Y return CAGR	12.43%
5Y total return	79.63%
6M price change	27.91%
6M total return	29.69%
All-time high	$103.65
All-time high date	2026-10-22
All-time low	$11.37
All-time low date	2009-03-06
Average true range (ATR)	$2.09
Average volume	3M
Beta (1Y)	0.74
Beta (2Y)	0.92
Beta (5Y)	0.77
Change from 52-week high	-3.91%
Change from 52-week low	47.93%
Change from all-time high	-4.15%
Change from all-time low	773.79%
Change from open	-0.73%
Day's gap	0.35%
Dollar volume	$142.2M
High price	$100.33
Low price	$99.37
Monthly RSI	67.25
Open price	$100.33
Position in 52-week range	23.96%
Premarket change	0.19%
Premarket close	$99.98
Premarket price	$100.17
Previous close	$99.98
Price vs 150-day SMA	11.54%
Price vs 20-day SMA	0.27%
Price vs 200-day SMA	16.25%
Price vs 50-day SMA	1.97%
Relative volume	0.47
RSI	51.45
Sharpe ratio	1.05
Sharpe ratio (3Y)	0.8
Sharpe ratio (5Y)	0.4
Sortino ratio	1.76
Sortino ratio (3Y)	1.34
Sortino ratio (5Y)	0.77
Volume	1.4M
Weekly RSI	63.82
YTD price change	25.86%
YTD total return	28.52%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	531.2M
Float percentage	83.6%
Shares change (QoQ)	-1.34%
Shares change (YoY)	-4.7%
Shares held by insiders	0.24%
Shares held by institutions	77.56%
Shares outstanding	635.5M
Short % of float	2.11%
Short % of shares	1.76%
Short ratio	3.7 days

Deeper analysis on MET

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MET report

Is a complete MET research report available?

No complete published report is available for MetLife, Inc. (MET) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MetLife, Inc. (MET)

Price

Financial snapshot

Fair-value bridge

Latest news · MET

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MET indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MET

Frequently asked questions